• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转化酶 2 在调节肠道微生物群、肠道炎症和冠状病毒感染中的作用。

The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.

机构信息

Life Sciences Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada; Department of Genetics, Medical University of Vienna, Vienna, Austria; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

Department of Ophthalmology and Visual Sciences, University of Alabama, Birmingham, Alabama.

出版信息

Gastroenterology. 2021 Jan;160(1):39-46. doi: 10.1053/j.gastro.2020.07.067. Epub 2020 Oct 30.

DOI:10.1053/j.gastro.2020.07.067
PMID:33130103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836226/
Abstract

The role of angiotensin converting enzyme 2 has expanded from regulating the renin angiotensin system to regulating intestinal amino acid homeostasis and the gut microbiome. Recently, angiotensin converting enzyme 2 was identified as a primary receptor for severe acute respiratory syndrome coronaviruses 1 and 2 being expressed in multiple tissues including the luminal surface of the gut. In this brief perspective, we examine the role of angiotensin converting enzyme 2 as the receptor for severe acute respiratory syndrome coronavirus 2 and the impact of coronavirus disease 19 infection on the gut microbiome and on the gut epithelium.

摘要

血管紧张素转换酶 2 的作用已经从调节肾素-血管紧张素系统扩展到调节肠道氨基酸稳态和肠道微生物组。最近,血管紧张素转换酶 2 被确定为严重急性呼吸综合征冠状病毒 1 和 2 的主要受体,在包括肠道腔表面在内的多种组织中表达。在这篇简短的观点文章中,我们研究了血管紧张素转换酶 2 作为严重急性呼吸综合征冠状病毒 2 受体的作用,以及冠状病毒病 19 感染对肠道微生物组和肠道上皮的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2f/7836226/81a04164b5b7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2f/7836226/8821cb6602bb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2f/7836226/81a04164b5b7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2f/7836226/8821cb6602bb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b2f/7836226/81a04164b5b7/gr2_lrg.jpg

相似文献

1
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.血管紧张素转化酶 2 在调节肠道微生物群、肠道炎症和冠状病毒感染中的作用。
Gastroenterology. 2021 Jan;160(1):39-46. doi: 10.1053/j.gastro.2020.07.067. Epub 2020 Oct 30.
2
The Renin-Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor.肾素-血管紧张素系统通过ACE2受体调节新型冠状病毒2型(SARS-CoV-2)的进入。
Viruses. 2025 Jul 19;17(7):1014. doi: 10.3390/v17071014.
3
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2(血管紧张素转换酶 2):对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
4
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.小鼠血管紧张素转换酶2(ACE2)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染易感性的决定因素。
J Virol. 2025 Jun 17;99(6):e0054325. doi: 10.1128/jvi.00543-25. Epub 2025 May 12.
5
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023.从肾脏到新型冠状病毒2:2023年唐纳德·塞尔丁奖讲座。 (注:ACE2一般指血管紧张素转换酶2,这里结合全文可能是与新型冠状病毒2相关的内容,但原文中未明确展开解释ACE2具体在这个语境下的详细含义,直接按字面呈现其英文缩写形式。)
Hypertension. 2025 Feb;82(2):166-180. doi: 10.1161/HYPERTENSIONAHA.124.22064. Epub 2024 Dec 3.
6
ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019).ACE2 作为新型冠状病毒(nCoV-2019)管理的潜在靶点。
Curr Drug Discov Technol. 2021;18(6):e130921189567. doi: 10.2174/1570163817999201228215911.
7
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.在病情静止或轻度活动的炎症性肠病(IBD)患者的肠黏膜中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宿主细胞进入基因的表达较低。
Inflamm Bowel Dis. 2025 Jun 13;31(6):1690-1701. doi: 10.1093/ibd/izaf079.
8
Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.调整 ACE/ACE2 失衡治疗 COVID-19 肺部病变的科学假说。
Cardiovasc Toxicol. 2021 Jun;21(6):498-503. doi: 10.1007/s12012-021-09649-y. Epub 2021 Apr 9.
9
A novel cellular tool for screening human pan-coronavirus antivirals.一种用于筛选抗人类泛冠状病毒药物的新型细胞工具。
Antiviral Res. 2025 Aug;240:106212. doi: 10.1016/j.antiviral.2025.106212. Epub 2025 Jun 10.
10
A MERS-CoV-like mink coronavirus uses ACE2 as an entry receptor.一种类似中东呼吸综合征冠状病毒的水貂冠状病毒利用血管紧张素转换酶2作为进入受体。
Nature. 2025 Jun;642(8068):739-746. doi: 10.1038/s41586-025-09007-w. Epub 2025 Apr 30.

引用本文的文献

1
Naturally occurring prenylated flavonoids from African plant species.来自非洲植物物种的天然异戊烯基化黄酮类化合物。
RSC Adv. 2025 Aug 18;15(34):27816-27847. doi: 10.1039/d5ra03457d. eCollection 2025 Aug 1.
2
A Series of Severe and Critical COVID-19 Cases in Hospitalized, Unvaccinated Children: Clinical Findings and Hospital Care.一系列未接种疫苗的住院儿童的重症和危重症 COVID-19 病例:临床发现与医院护理
Epidemiologia (Basel). 2025 Aug 4;6(3):40. doi: 10.3390/epidemiologia6030040.
3
Modeling mammalian hibernation to improve organ cold preservation: Using the intestine as an example.

本文引用的文献

1
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.SARS-CoV-2 感染与 ACE2:与糖尿病患者发病率和死亡率增加相关的临床结局。
Diabetes. 2020 Sep;69(9):1875-1886. doi: 10.2337/dbi20-0019. Epub 2020 Jul 15.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19.
模拟哺乳动物冬眠以改善器官低温保存:以肠道为例。
Cell Res. 2025 Jul 28. doi: 10.1038/s41422-025-01149-w.
4
Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies.新冠病毒感染后消化系统表现:聚焦治疗策略
Pathogens. 2025 Jun 3;14(6):555. doi: 10.3390/pathogens14060555.
5
Impact of Glucose, Inflammation and Phytochemicals on , and Glucose Transporter Gene Expression in Human Intestinal Cells.葡萄糖、炎症和植物化学物质对人肠道细胞中、和葡萄糖转运蛋白基因表达的影响
Antioxidants (Basel). 2025 Feb 21;14(3):253. doi: 10.3390/antiox14030253.
6
Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health.肠道微生物群在长期新冠中的作用:对免疫功能和器官系统健康的影响
Arch Microbiol Immunol. 2025;9(1):38-53. Epub 2025 Feb 4.
7
Heart Failure and Gut Microbiota: What Is Cause and Effect?心力衰竭与肠道微生物群:何为因,何为果?
Research (Wash D C). 2025 Feb 20;8:0610. doi: 10.34133/research.0610. eCollection 2025.
8
Molecular dissection of the role of ACE2 in glucose homeostasis.血管紧张素转换酶2(ACE2)在葡萄糖稳态中作用的分子剖析
Physiol Rev. 2025 Jul 1;105(3):935-973. doi: 10.1152/physrev.00027.2024. Epub 2025 Feb 7.
9
The role of gut-islet axis in pancreatic islet function and glucose homeostasis.肠-胰岛轴在胰岛功能和葡萄糖稳态中的作用。
Diabetes Obes Metab. 2025 Apr;27(4):1676-1692. doi: 10.1111/dom.16225. Epub 2025 Feb 6.
10
Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2).衰老细胞溶解疗法通过上调血管紧张素转换酶2(ACE2)减轻角膜移植排斥反应。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):15. doi: 10.1167/iovs.66.2.15.
新型冠状病毒肺炎患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的使用、胃肠道症状与死亡率之间的关联
Gastroenterology. 2020 Sep;159(3):1170-1172.e1. doi: 10.1053/j.gastro.2020.05.034. Epub 2020 May 16.
4
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review.粪便中 SARS-CoV-2 的持续病毒脱落——快速综述。
Colorectal Dis. 2020 Jun;22(6):611-620. doi: 10.1111/codi.15138. Epub 2020 Jun 4.
5
Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor and in Inflammatory Bowel Disease.年龄、炎症和疾病部位是炎症性肠病中 SARS-CoV-2 受体肠道表达的关键决定因素。
Gastroenterology. 2020 Sep;159(3):1151-1154.e2. doi: 10.1053/j.gastro.2020.05.030. Epub 2020 May 12.
6
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者胃肠道及肝脏受累的表现和预后:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. doi: 10.1016/S2468-1253(20)30126-6. Epub 2020 May 12.
7
Infection of bat and human intestinal organoids by SARS-CoV-2.新冠病毒感染蝙蝠和人类肠类器官。
Nat Med. 2020 Jul;26(7):1077-1083. doi: 10.1038/s41591-020-0912-6. Epub 2020 May 13.
8
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.TMPRSS2 和 TMPRSS4 促进 SARS-CoV-2 感染人小肠肠细胞。
Sci Immunol. 2020 May 13;5(47). doi: 10.1126/sciimmunol.abc3582.
9
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞:一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
10
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.